Healthcare provider profile · identity verified

Azadeh Ghassemi, MD

Internal Medicine · MOSES LAKE, WA · NPI 1912569674

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	447	179
Amlodipine Besylate	Amlodipine Besylate	441	175
Losartan Potassium	Losartan Potassium	318	140
Lisinopril	Lisinopril	274	114
Levothyroxine Sodium	Levothyroxine Sodium	220	85
Metoprolol Succinate	Metoprolol Succinate	181	82
Gabapentin	Gabapentin	166	63
Hydrochlorothiazide	Hydrochlorothiazide	165	68
Rosuvastatin Calcium	Rosuvastatin Calcium	143	62
Potassium Chloride	Potassium Chloride	139	65
Pravastatin Sodium	Pravastatin Sodium	139	56
Omeprazole	Omeprazole	130	58
Metformin Hcl	Metformin Hcl	124	53
Furosemide	Furosemide	109	49
Estradiol	Estradiol	93	60
Metformin Hcl Er	Metformin Hcl	92	39
Tamsulosin Hcl	Tamsulosin Hcl	89	41
Alendronate Sodium	Alendronate Sodium	84	42
Pantoprazole Sodium	Pantoprazole Sodium	79	33
Metoprolol Tartrate	Metoprolol Tartrate	76	36
Triamcinolone Acetonide	Triamcinolone Acetonide	64	38
Benazepril Hcl	Benazepril Hcl	63	23
Ozempic	Semaglutide	62	17
Albuterol Sulfate Hfa	Albuterol Sulfate	61	38
Trazodone Hcl	Trazodone Hcl	60	22
Duloxetine Hcl	Duloxetine Hcl	55	23
Citalopram Hbr	Citalopram Hydrobromide	54	24
Spironolactone	Spironolactone	54	28
Carvedilol	Carvedilol	52	23
Allopurinol	Allopurinol	50	23
Ezetimibe	Ezetimibe	50	21
Glipizide	Glipizide	50	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	38
Eliquis	Apixaban	43	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	22
Chlorthalidone	Chlorthalidone	38	15
Escitalopram Oxalate	Escitalopram Oxalate	38	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	15
Januvia	Sitagliptin Phosphate	37	16
Tramadol Hcl	Tramadol Hcl	36	16
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Jardiance	Empagliflozin	33	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Meloxicam	Meloxicam	31	13
Clonidine Hcl	Clonidine Hcl	29	11
Clopidogrel	Clopidogrel Bisulfate	29	14
Fluticasone Propionate	Fluticasone Propionate	29	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Simvastatin	Simvastatin	27	12
Synthroid	Levothyroxine Sodium	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	14
Pregabalin	Pregabalin	25	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Baclofen	Baclofen	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Nystatin	Nystatin	20	14
Prednisone	Prednisone	20	16
Montelukast Sodium	Montelukast Sodium	19	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Mirtazapine	Mirtazapine	18	13
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Azithromycin	Azithromycin	17	15
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Famotidine	Famotidine	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Valsartan	Valsartan	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Finasteride	Finasteride	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Lorazepam	Lorazepam	13	11
Rybelsus	Semaglutide	13	suppressed
Atenolol	Atenolol	12	suppressed
Diclofenac Potassium	Diclofenac Potassium	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Ramipril	Ramipril	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Primidone	Primidone	11	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error